B of A Securities Upgrades AmerisourceBergen to Buy, Raises Price Target to $169
B of A Securities analyst Michael Cherny upgrades AmerisourceBergen (NYSE:ABC) from Neutral to Buy and raises the price target from $160 to $169.
‘I’m Not Going There,’ Cramer Says About This Energy Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc (NASDAQ: PATH) is losing money, and he is not recommending companies that are losing money.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
AmerisourceBergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex For €1.28B In Cash
Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners
AmerisourceBergen Corporation (NYSE:ABC) today announced that it has signed a
Morgan Stanley Maintains Equal-Weight on AmerisourceBergen, Raises Price Target to $176
Morgan Stanley analyst Ricky Goldwasser maintains AmerisourceBergen (NYSE:ABC) with a Equal-Weight and raises the price target from $175 to $176.
Credit Suisse Maintains Outperform on AmerisourceBergen, Lowers Price Target to $175
Credit Suisse analyst A.J. Rice maintains AmerisourceBergen (NYSE:ABC) with a Outperform and lowers the price target from $180 to $175.
AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations
AmerisourceBergen Corp’s (NYSE:ABC) Q3 FY22 adjusted EPS reached $2.62, up 21.3% Y/Y, beating the consensus of $2.57. Revenue of $60.1…
AmerisourceBergen: Q3 Earnings Insights
AmerisourceBergen (NYSE:ABC) reported its Q3 earnings results on Wednesday, August 3, 2022 at 08:30 AM.
Here's what investors need to know about the announcement.
Argus Research Maintains Buy on AmerisourceBergen, Raises Price Target to $170
Argus Research analyst David Toung maintains AmerisourceBergen (NYSE:ABC) with a Buy and raises the price target from $160 to $170.
$1000 Invested In AmerisourceBergen 10 Years Ago Would Be Worth This Much Today
AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years by 2.61% on an annualized basis producing an average annual return of 13.54%. Currently, AmerisourceBergen has a market capitalization of $29.70 billion.